EVALUATION OF ANTI-SECRETORY DRUG-THERAPY OF ZOLLINGER-ELLISON SYNDROME (ZES) USING 24-HOUR PH MONITORING

被引：53

作者：

VALLOT, T ^{[1
]}

MIGNON, M ^{[1
]}

MAZURE, R ^{[1
]}

BONFILS, S ^{[1
]}

机构：

[1] HOP BICHAT,MALAD APPAREIL DIGEST CLIN,INSERM,U10,UNITE RECH GASTROENTEROL,F-75877 PARIS 18,FRANCE

来源：

关键词：

D O I：

10.1007/BF01299916

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：577 / 584

页数：8

共 21 条

[1]

Bonfils S, 1979, World J Surg, V3, P597

[2]

BONFILS S, 1980, NEW ENGL J MED, V303, P942

[3]

BONFILS S, 1982, DIGEST DIS SCI, V27, P377

[4]

BONFILS S, 1977, CIMETIDINE, P311

[5]

BONFILS S, 1981, DRUGS PEPTIC ULCER, V1, P66

CAREY, PF ;

MARTIN, LE .

JOURNAL OF LIQUID CHROMATOGRAPHY, 1979, 2 (09) :1291-1303

[7]

COLLINS SM, 1981, GASTROENTEROLOGY, V80, P1127

[8] GASTRIC-EMPTYING AND SECRETION IN ZOLLINGER-ELLISON SYNDROME [J].

DUBOIS, A ;

VANEERDEWEGH, P ;

GARDNER, JD .

[9]

GALMICHE JP, 1982, GASTROEN CLIN BIOL, V6, P352

[10]

HARRISON A, 1980, GASTROENTEROLOGY, V78, P1181